{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:16:42Z","timestamp":1756635402305},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,29]],"date-time":"2009-11-29T00:00:00Z","timestamp":1259452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11906-009-0071-0","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T06:04:06Z","timestamp":1259388246000},"page":"412-420","source":"Crossref","is-referenced-by-count":5,"title":["Myocardial remodeling in low-renin hypertension: Molecular pathways to cellular injury in relative aldosteronism"],"prefix":"10.1007","volume":"11","author":[{"given":"Syamal K.","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay S.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Kamalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Ahokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan C.","family":"Gerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,29]]},"reference":[{"key":"71_CR1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.HYP.17.6.1161","volume":"17","author":"S. Julius","year":"1991","unstructured":"Julius S, Li Y, Brant D, et al.: Quinapril, an angiotensin converting enzyme inhibitor, prevents cardiac hypertrophy during episodic hypertension. Hypertension 1991, 17:1161\u20131166.","journal-title":"Hypertension"},{"issue":"SupplD","key":"71_CR2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/eurheartj\/13.suppl_D.66","volume":"13","author":"F.H. Messerli","year":"1992","unstructured":"Messerli FH, Grodzicki T: Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992, 13(Suppl D):66\u201369.","journal-title":"Eur Heart J"},{"key":"71_CR3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/hrt.51.6.637","volume":"51","author":"L.M. Shapiro","year":"1984","unstructured":"Shapiro LM, McKenna WJ: Left ventricular hypertrophy: relation of structure to diastolic function in hypertension. Br Heart J 1984, 51:637\u2013642.","journal-title":"Br Heart J"},{"key":"71_CR4","first-page":"353","volume":"18","author":"N. Sugihara","year":"1988","unstructured":"Sugihara N, Genda A, Shimizu M, et al.: Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension. J Cardiol 1988, 18:353\u2013361.","journal-title":"J Cardiol"},{"key":"71_CR5","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","volume":"105","author":"J. D\u00edez","year":"2002","unstructured":"D\u00edez J, Querejeta R, L\u00f3pez B, et al.: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512\u20132517.","journal-title":"Circulation"},{"key":"71_CR6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0735-1097(10)80135-4","volume":"17","author":"J.K. Ghali","year":"1991","unstructured":"Ghali JK, Kadakia S, Cooper RS, Liao Y: Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol 1991, 17:1277\u20131282.","journal-title":"J Am Coll Cardiol"},{"key":"71_CR7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9149(90)90807-D","volume":"65","author":"R.S. Cooper","year":"1990","unstructured":"Cooper RS, Simmons BE, Castaner A, et al.: Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990, 65:441\u2013445.","journal-title":"Am J Cardiol"},{"key":"71_CR8","first-page":"158","volume":"46","author":"E.S. Pearlman","year":"1982","unstructured":"Pearlman ES, Weber KT, Janicki JS, et al.: Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982, 46:158\u2013164.","journal-title":"Lab Invest"},{"key":"71_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0344-0338(89)80162-1","volume":"184","author":"J.A.N. Huysman","year":"1989","unstructured":"Huysman JAN, Vliegen HW, Van der Laarse A, Eulderink F: Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts. Pathol Res Pract 1989, 184:577\u2013581.","journal-title":"Pathol Res Pract"},{"key":"71_CR10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00004872-199816070-00018","volume":"16","author":"M.A. Rossi","year":"1998","unstructured":"Rossi MA: Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998, 16:1031\u20131041.","journal-title":"J Hypertens"},{"key":"71_CR11","first-page":"205","volume-title":"Cardiovascular Diseases in Blacks","author":"R.S. Cooper","year":"1991","unstructured":"Cooper RS, Ghali JK: Coronary heart disease: blackwhite differences. In Cardiovascular Diseases in Blacks. Edited by Saunders E. Philadelphia: F. A. Davis; 1991:205\u2013225."},{"key":"71_CR12","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/archinte.1988.00380090087021","volume":"148","author":"J.K. Ghali","year":"1988","unstructured":"Ghali JK, Kadakia S, Cooper R, Ferlinz J: Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988, 148:2013\u20132016.","journal-title":"Arch Intern Med"},{"key":"71_CR13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197203022860901","volume":"286","author":"H.R. Brunner","year":"1972","unstructured":"Brunner HR, Laragh JH, Baer L, et al.: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972, 286:441\u2013449.","journal-title":"N Engl J Med"},{"key":"71_CR14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI106974","volume":"51","author":"G.H. Williams","year":"1972","unstructured":"Williams GH, Cain JP, Dluhy RG, Underwood RH: Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading. J Clin Invest 1972, 51:1731\u20131742.","journal-title":"J Clin Invest"},{"key":"71_CR15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI106359","volume":"49","author":"R.D. Collins","year":"1970","unstructured":"Collins RD, Weinberger MH, Dowdy AJ, et al.: Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Invest 1970, 49:1415\u20131426.","journal-title":"J Clin Invest"},{"key":"71_CR16","doi-asserted-by":"crossref","first-page":"III143","DOI":"10.1161\/01.HYP.18.5_Suppl.III143","volume":"18","author":"G.H. Williams","year":"1991","unstructured":"Williams GH, Hollenberg NK: Functional derangements in the regulation of aldosterone secretion in hypertension. Hypertension 1991, 18:III143\u2013III149.","journal-title":"Hypertension"},{"key":"71_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-105-5-649","volume":"105","author":"L.M. Resnick","year":"1986","unstructured":"Resnick LM, M\u00fcller FB, Laragh JH: Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986, 105:649\u2013654.","journal-title":"Ann Intern Med"},{"key":"71_CR18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","volume":"8","author":"E. Rossi","year":"1995","unstructured":"Rossi E, Sani C, Perazzoli F, et al.: Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 1995, 8:884\u2013893.","journal-title":"Am J Hypertens"},{"key":"71_CR19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1172\/JCI111995","volume":"76","author":"N.H. Bell","year":"1985","unstructured":"Bell NH, Greene A, Epstein S, et al.: Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985, 76:470\u2013473.","journal-title":"J Clin Invest"},{"key":"71_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5414\/CNP57051","volume":"57","author":"B.P. Sawaya","year":"2002","unstructured":"Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, et al.: Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol 2002, 57:51\u201355.","journal-title":"Clin Nephrol"},{"key":"71_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MAJ.0b013e318167b0bd","volume":"335","author":"S. Alsafwah","year":"2008","unstructured":"Alsafwah S, LaGuardia SP, Nelson MD, et al.: Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008, 335:292\u2013297.","journal-title":"Am J Med Sci"},{"key":"71_CR22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-22-12-1187","volume":"22","author":"R. Horton","year":"1962","unstructured":"Horton R, Biglieri EG: Effect of aldosterone on the metabolism of magnesium. J Clin Endocrinol Metab 1962, 22:1187\u20131192.","journal-title":"J Clin Endocrinol Metab"},{"key":"71_CR23","first-page":"871","volume":"183","author":"J.W. Conn","year":"1963","unstructured":"Conn JW: Aldosteronism in man. Some clinical and climatological aspects. Part II. JAMA 1963, 183:871\u2013878.","journal-title":"JAMA"},{"issue":"Suppl2","key":"71_CR24","first-page":"27","volume":"38","author":"J.L. Garcia Zozaya","year":"1997","unstructured":"Garcia Zozaya JL, Padilla Viloria M: [Alterations of calcium, magnesium, and zinc in essential hypertension: their relation to the renin-angiotensin-aldosterone system] [Spanish]. Invest Clin 1997, 38(Suppl 2):27\u201340.","journal-title":"Invest Clin"},{"key":"71_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1385\/BTER:107:2:089","volume":"107","author":"S. Tubek","year":"2005","unstructured":"Tubek S: Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension. Biol Trace Elem Res 2005, 107:89\u201399.","journal-title":"Biol Trace Elem Res"},{"key":"71_CR26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0278-6915(99)00145-3","volume":"38","author":"A.J. Cohen","year":"2000","unstructured":"Cohen AJ, Roe FJ: Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem Toxicol 2000, 38:237\u2013253.","journal-title":"Food Chem Toxicol"},{"key":"71_CR27","first-page":"15","volume":"51","author":"A. Fleckenstein","year":"1967","unstructured":"Fleckenstein A: [Metabolic problems in myocardium insufficiency] [German]. Verh Dtsch Ges Pathol 1967, 51:15\u201330.","journal-title":"Verh Dtsch Ges Pathol"},{"key":"71_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007740050101","volume":"18","author":"T. Fujita","year":"2000","unstructured":"Fujita T, Palmieri GM: Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 2000, 18:109\u2013125.","journal-title":"J Bone Miner Metab"},{"key":"71_CR29","first-page":"219","volume":"14","author":"S.G. Massry","year":"1994","unstructured":"Massry SG, Smogorzewski M: Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 1994, 14:219\u2013231.","journal-title":"Semin Nephrol"},{"key":"71_CR30","first-page":"H1998","volume":"264","author":"M. Smogorzewski","year":"1993","unstructured":"Smogorzewski M, Zayed M, Zhang YB, et al.: Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 1993, 264:H1998\u2013H2006.","journal-title":"Am J Physiol"},{"issue":"6Pt2","key":"71_CR31","first-page":"H1945","volume":"261","author":"D. Rampe","year":"1991","unstructured":"Rampe D, Lacerda AE, Dage RC, Brown AM: Parathyroid hormone: an endogenous modulator of cardiac calcium channels. Am J Physiol 1991, 261(6 Pt 2):H1945\u2013H1950.","journal-title":"Am J Physiol"},{"key":"71_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvp027","volume":"82","author":"I. Tastan","year":"2009","unstructured":"Tastan I, Schreckenberg R, Mufti S, et al.: Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a nonacute way. Cardiovasc Res 2009, 82:77\u201383.","journal-title":"Cardiovasc Res"},{"key":"71_CR33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","volume":"40","author":"A. Virdis","year":"2002","unstructured":"Virdis A, Neves MF, Amiri F, et al.: Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002, 40:504\u2013510.","journal-title":"Hypertension"},{"key":"71_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","volume":"42","author":"Q. Pu","year":"2003","unstructured":"Pu Q, Neves MF, Virdis A, et al.: Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 2003, 42:49\u201355.","journal-title":"Hypertension"},{"key":"71_CR35","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y. Sun","year":"2002","unstructured":"Sun Y, Zhang J, Lu L, et al.: Aldosterone-induced inflammation in the rat heart. Role of oxidative stress. Am J Pathol 2002, 161:1773\u20131781.","journal-title":"Am J Pathol"},{"key":"71_CR36","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00113.2003","volume":"285","author":"I.C. Gerling","year":"2003","unstructured":"Gerling IC, Sun Y, Ahokas RA, et al.: Aldosteronism: an immunostimulatory state precedes the proinflammatory\/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol 2003, 285:H813\u2013H821.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"71_CR37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.HYP.2.2.162","volume":"2","author":"D.A. McCarron","year":"1980","unstructured":"McCarron DA, Pingree PA, Rubin RJ, et al.: Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 1980, 2:162\u2013168.","journal-title":"Hypertension"},{"key":"71_CR38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","volume":"115","author":"A.U. Klingbeil","year":"2003","unstructured":"Klingbeil AU, Schneider M, Martus P, et al.: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003, 115:41\u201346.","journal-title":"Am J Med"},{"key":"71_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-147-5-200709040-00006","volume":"147","author":"P.M. Okin","year":"2007","unstructured":"Okin PM, Devereux RB, Harris KE, et al.: Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med 2007, 147:311\u2013319.","journal-title":"Ann Intern Med"},{"key":"71_CR40","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","volume":"292","author":"P.M. Okin","year":"2004","unstructured":"Okin PM, Devereux RB, Jern S, et al.: Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004, 292:2343\u20132349.","journal-title":"JAMA"},{"key":"71_CR41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacc.2003.11.029","volume":"43","author":"S. Julius","year":"2004","unstructured":"Julius S, Alderman MH, Beevers G, et al.: Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol 2004, 43:1047\u20131055.","journal-title":"J Am Coll Cardiol"},{"key":"71_CR42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"C.G. Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, et al.: Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 1990, 67:1355\u20131364.","journal-title":"Circ Res"},{"key":"71_CR43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","volume":"35","author":"Y. Sun","year":"1997","unstructured":"Sun Y, Ramires FJA, Weber KT: Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997, 35:138\u2013147.","journal-title":"Cardiovasc Res"},{"key":"71_CR44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.25.6.1135","volume":"25","author":"E.L. Schiffrin","year":"1995","unstructured":"Schiffrin EL: Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995, 25:1135\u20131143.","journal-title":"Hypertension"},{"key":"71_CR45","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","volume":"345","author":"K.T. Weber","year":"2001","unstructured":"Weber KT: Aldosterone in congestive heart failure. N Engl J Med 2001, 345:1689\u20131697.","journal-title":"N Engl J Med"},{"key":"71_CR46","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","volume":"93","author":"M. Young","year":"1994","unstructured":"Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994, 93:2578\u20132583.","journal-title":"J Clin Invest"},{"key":"71_CR47","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","volume":"110","author":"A. Garnier","year":"2004","unstructured":"Garnier A, Bendall JK, Fuchs S, et al.: Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation 2004, 110:1819\u20131825.","journal-title":"Circulation"},{"key":"71_CR48","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.101.14.1722","volume":"101","author":"M.J. Somers","year":"2000","unstructured":"Somers MJ, Mavromatis K, Galis ZS, Harrison DG: Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000, 101:1722\u20131728.","journal-title":"Circulation"},{"key":"71_CR49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/FJC.0b013e3181833eb8","volume":"52","author":"M.S. Gandhi","year":"2008","unstructured":"Gandhi MS, Deshmukh PA, Kamalov G, et al.: Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism. J Cardiovasc Pharmacol 2008, 52:245\u2013252.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"SupplH","key":"71_CR50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/eurheartj\/4.suppl_H.43","volume":"4","author":"A. Fleckenstein","year":"1983","unstructured":"Fleckenstein A, Frey M, Fleckenstein-Grun G: Consequences of uncontrolled calcium entry and its prevention with calcium antagonists. Eur Heart J 1983, 4(Suppl H):43\u201350.","journal-title":"Eur Heart J"},{"key":"71_CR51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"V.S. Chhokar","year":"2005","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK, et al.: Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005, 111:871\u2013878.","journal-title":"Circulation"},{"key":"71_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.CIR.0000151516.84238.37","volume":"111","author":"R.A. Ahokas","year":"2005","unstructured":"Ahokas RA, Sun Y, Bhattacharya SK, et al.: Aldosteronism and a proinflammatory vascular phenotype. Role of Mg2+, Ca2+ and H2O2 in peripheral blood mononuclear cells. Circulation 2005, 111:51\u201357.","journal-title":"Circulation"},{"key":"71_CR53","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1161\/01.RES.0000102404.81461.25","volume":"93","author":"R.A. Ahokas","year":"2003","unstructured":"Ahokas RA, Warrington KJ, Gerling IC, et al.: Aldosteronism and peripheral blood mononuclear cell activation. A neuro endocrine-immune interface. Circ Res 2003, 93:e124\u2013e135.","journal-title":"Circ Res"},{"key":"71_CR54","doi-asserted-by":"crossref","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","volume":"287","author":"V.S. Chhokar","year":"2004","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK, et al.: Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol 2004, 287:H2023\u2013H2026.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"71_CR55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(87)90268-3","volume":"82","author":"D.A. McCarron","year":"1987","unstructured":"McCarron DA, Morris CD, Bukoski R: The calcium paradox of essential hypertension. Am J Med 1987, 82:27\u201333.","journal-title":"Am J Med"},{"key":"71_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000441-200608000-00004","volume":"332","author":"K.D. Goodwin","year":"2006","unstructured":"Goodwin KD, Ahokas RA, Bhattacharya SK, et al.: Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. Am J Med Sci 2006, 332:73\u201378.","journal-title":"Am J Med Sci"},{"key":"71_CR57","doi-asserted-by":"crossref","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","volume":"290","author":"A. Vidal","year":"2006","unstructured":"Vidal A, Sun Y, Bhattacharya SK, et al.: Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006, 290:H286\u2013H294.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"71_CR58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MAJ.0b013e318134f013","volume":"335","author":"Y. Selektor","year":"2008","unstructured":"Selektor Y, Ahokas RA, Bhattacharya SK, et al.: Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism. Am J Med Sci 2008, 335:105\u2013110.","journal-title":"Am J Med Sci"},{"key":"71_CR59","doi-asserted-by":"crossref","first-page":"H2361","DOI":"10.1152\/ajpheart.00200.2007","volume":"293","author":"M. Thomas","year":"2007","unstructured":"Thomas M, Vidal A, Bhattacharya SK, et al.: Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone. Am J Physiol Heart Circ Physiol 2007, 293:H2361\u2013H2366.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"71_CR60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/FJC.0b013e318165b96e","volume":"51","author":"Y. Selektor","year":"2008","unstructured":"Selektor Y, Parker RB, Sun Y, et al.: Tissue 65Zinc translocation in a rat model of chronic aldosteronism. J Cardiovasc Pharmacol 2008, 51:359\u2013364.","journal-title":"J Cardiovasc Pharmacol"},{"key":"71_CR61","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2174\/092986708785747490","volume":"15","author":"L. Aureli","year":"2008","unstructured":"Aureli L, Gioia M, Cerbara I, et al.: Structural bases for substrate and inhibitor recognition by matrix metalloproteinases. Curr Med Chem 2008, 15:2192\u20132222.","journal-title":"Curr Med Chem"},{"key":"71_CR62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/FJC.0b013e3181a15e77","volume":"53","author":"G. Kamalov","year":"2009","unstructured":"Kamalov G, Deshmukh PA, Baburyan NY, et al.: Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism. J Cardiovasc Pharmacol 2009, 53:414\u2013423.","journal-title":"J Cardiovasc Pharmacol"},{"key":"71_CR63","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.105.537894","volume":"113","author":"J. Wang","year":"2006","unstructured":"Wang J, Song Y, Elsherif L, et al.: Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 2006, 113:544\u2013554.","journal-title":"Circulation"},{"key":"71_CR64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/jpet.107.119644","volume":"321","author":"G. Karagulova","year":"2007","unstructured":"Karagulova G, Yue Y, Moreyra A, et al.: Protective role of intracellular zinc in myocardial ischemia\/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther 2007, 321:517\u2013525.","journal-title":"J Pharmacol Exp Ther"},{"key":"71_CR65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-2828(77)90046-3","volume":"9","author":"M. Chvapil","year":"1977","unstructured":"Chvapil M, Owen JA: Effect of zinc on acute and chronic isoproterenol induced heart injury. J Mol Cell Cardiol 1977, 9:151\u2013159.","journal-title":"J Mol Cell Cardiol"},{"key":"71_CR66","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1172\/JCI110299","volume":"68","author":"G.M. Palmieri","year":"1981","unstructured":"Palmieri GM, Nutting DF, Bhattacharya SK, et al.: Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris. J Clin Invest 1981, 68:646\u2013654.","journal-title":"J Clin Invest"},{"key":"71_CR67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.880050114","volume":"5","author":"S.K. Bhattacharya","year":"1982","unstructured":"Bhattacharya SK, Palmieri GM, Bertorini TE, Nutting DF: The effects of diltiazem in dystrophic hamsters. Muscle Nerve 1982, 5:73\u201378.","journal-title":"Muscle Nerve"},{"key":"71_CR68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-4886(87)90137-3","volume":"95","author":"A.J. Crawford","year":"1987","unstructured":"Crawford AJ, Bhattacharya SK: Excessive intracellular zinc accumulation in cardiac and skeletal muscles of dystrophic hamsters. Exp Neurol 1987, 95:265\u2013276.","journal-title":"Exp Neurol"},{"key":"71_CR69","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.mcna.2009.02.002","volume":"93","author":"J. D\u00edez","year":"2009","unstructured":"D\u00edez J: Towards a new paradigm about hypertensive heart disease. Med Clin North Am 2009, 93:637\u2013645.","journal-title":"Med Clin North Am"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-009-0071-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-009-0071-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-009-0071-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:24Z","timestamp":1559434464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-009-0071-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,29]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1007\/s11906-009-0071-0","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,29]]}}}